SCHEMBL22554927

SCHEMBL22554927

Cc1ccc2c(c1)[CH]CC(C)O2

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CREBBP Q92793 2/20 0.44
▸ BRD4 O60885 1/20 0.44
▸ AKR1B1 P15121 1/20 0.38
▸ PTGS2 P35354 1/20 0.38
▸ MAPT P10636 2/20 0.35
▸ LMNA P02545 1/20 0.35
▸ TP53 P04637 1/20 0.35
▸ THRB P10828 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ TSHR P16473 1/20 0.33
▸ NPSR1 Q6W5P4 1/20 0.33
▸ TDP1 Q9NUW8 1/20 0.33
▸ PBRM1 Q86U86 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ GAA P10253 1/20 0.33
▸ HSD17B10 Q99714 1/20 0.33
▸ CYP1A2 P05177 1/20 0.32
▸ CYP2A6 P11509 1/20 0.32
▸ MAOB P27338 3/20 0.31
▸ KDM4E B2RXH2 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9530592 0.75 BRD4 (0.40) CREBBPBRD4AKR1B1MAPTSMN1; SMN2
SCHEMBL15667344 0.69 TDP1 (0.57) CREBBPBRD4AKR1B1MAPTSMN1; SMN2
SCHEMBL15667383 0.69 TDP1 (0.57) CREBBPBRD4AKR1B1MAPTSMN1; SMN2
SCHEMBL318360 0.69 TDP1 (0.57) CREBBPBRD4AKR1B1MAPTSMN1; SMN2
SCHEMBL8404573 0.69 PTGS2 (0.40) CREBBPBRD4AKR1B1PTGS2MAPT
SCHEMBL8344689 0.68 CA2 (0.49) CREBBPBRD4AKR1B1MAPTALDH1A1
SCHEMBL10054037 0.68 CREBBP (0.45) CREBBPBRD4AKR1B1MAPTALDH1A1
SCHEMBL11926950 0.67 CREBBP (0.44) CREBBPBRD4AKR1B1MAPTTDP1
SCHEMBL18743290 0.67 CREBBP (0.44) CREBBPBRD4AKR1B1MAPTTDP1
SCHEMBL18643710 0.67 CREBBP (0.44) CREBBPBRD4AKR1B1MAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200331904-A1 3-AMINO-[1,2,4]-TRIAZOLE DERIVATIVES AND THEIR USE FOR CONTROLLING UNDESIRED PLANT GROWTH BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2020-10-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200331904-A1 3-AMINO-[1,2,4]-TRIAZOLE DERIVATIVES AND THEIR USE FOR CONTROLLING UNDESIRED PLANT GROWTH NAT1, AGXT, CYP4Z1 CREBBP 4300/4885BRD4 1058/4885AKR1B1 1210/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback